ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients

Liver Transplantation

Volumn 14, Issue 6, 2008, Pages 893-898

  Israeli, Moshe ^a,b   Klein, Tirza ^a,d   Sredni, Benjamin ^b   Avitzur, Yaron ^d   Mor, Eitan ^a   Bar Nathen, Nathan ^a   Steinberg, Ran ^c,d   Dinari, Gabriel ^c,d   Shapiro, Rivka ^c,d  

^a RABIN MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD4 ANTIGEN; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PHYTOHEMAGGLUTININ; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOLOGICAL PARAMETERS; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PATIENT MONITORING; PEDIATRIC SURGERY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY;

CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTEROLOGY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MODELS, BIOLOGICAL; MONITORING, IMMUNOLOGIC; PILOT PROJECTS;

EID: 46049093190     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21426     Document Type: Article

References (9)

1. Kowalski R, Post D, Schneider MC, Britz J, Thomas J, Deierhoi M, et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003;17:77-88.
2. Kowalski RJ, Post DR, Mannon RB, Sebastian A, Wright HI, Sigle G, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006:82:663-668.
3. Israeli M, Yussim A, Mor E, Sredni B, Klein T. Preceding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007;18:7-12.
4. Gautam A, Morrissey PE, Brem AS, Fischer SA, Gohh RY, Yango AF, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006;10:613-616.
5. Hooper E, Hawkins DM, Kowalski RJ, Post DR, Britz JA, Brooks KC, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005;19:834-839.
6. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393.
7. Danovitch GM. Handbook of Kidney Transplantation. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
8. Khera N, Janosky J, Zeevi A, Mazariegos G, Marcos A, Sindhi R. Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children. Front Biosci 2007;12:660-663.
9. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant 2004;4:384-389.